HTL Biotechnology
Dr. Kruti Patel is a highly experienced Senior Technical Manager at HTL Biotechnology, with prior roles as Scientist II at Waters Corporation and as an Adjunct Assistant Professor and Research Associate Scientist at the Botulinum Research Center. Dr. Patel specializes in the development and validation of analytical methods, vaccine development, and biochemistry, with a strong emphasis on botulinum toxin research. Academic credentials include a Ph.D. in Biochemistry from the University of Massachusetts Lowell and multiple advanced degrees in chemistry and biochemistry. Throughout the career, Dr. Patel has demonstrated expertise in analytics, troubleshooting quality systems, and conducting innovative research while also providing training and technical guidance in cross-functional settings.
This person is not in any offices
HTL Biotechnology
HTL is the world leader in the development and production of pharmaceutical grade biopolymers used to develop life-changing treatments for millions of patients. A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined for over 30 years its innovative functional biopolymer platform that has enabled it to produce "customised" pharmaceutical grade products for the leaders of the pharmaceutical and medical devices sectors in therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology and urology Thanks to its dedicated R&D team, its partnerships and its incubator, HTL is now driving innovation in the biopolymer sector. Its R&D strategy aims to address unmet medical needs by creating new types of biopolymers, modifying their physico-chemical properties, and exploring new medical applications in cutting-edge areas such as bioprinting and drug delivery. very.